Member Info for Saxondale

On the bright side we now have $16 million dollars in the pot to invest in the drillbit .
As another mentioned - in times of financial uncertainty - better to get it done now.
Confidence in the project very positive .

Another publication showing how the Delta variant is even more sensitive to interferons in the lung cells .
I expect most of the patients on Hibiscus will be contracted with the Delta variant as it is the dominant strain .

https://www.biorxiv.org/content/10.1101/2021.11.16.468777v1.full.pdf

All this data piling up in support of Interferon treatment .
With all the Bex hype , they certainly aren't hyping Hibiscus at the moment , despite it looking ( on paper at least ) to be potentially a billion dollar jackpot hit . And interim data expected in the coming weeks .

Agree with Redirons .
I'm also curious as to the real reason for placing .
I get what they plan on doing with the funds , but I think there might be something inbetween the lines.
Hav is going at full speed - not sure how you can fast track something even more - except for maybe getting your own extra rigs to explore these extra targets , rather than having to pull one off main duty .
Something also tells me they want to get out and test these sites ASAP .

Chances are you may get a similar price tomorrow , who knows . I can't be bothered to try and load an app and fiddle about , I'll just see how the SP does tomorrow and if it drops sufficiently I'll have a bite .
Done plenty of adding at 17p , held out on the 16's just incase something like this happened .

Oh well , at least my next top up will be at a good price .
Had to be done I suppose to keep them in the game .
At least its done now , and Shauns got a small amount of skin in the game - lets see how that money translates into some new developments .
This bit is encouraging -

The Company is concurrently progressing discussions with several Tier 1 global banks with the aim of providing significant additional funding to the Company for the development of Havieron in the medium-term. To date, the Company has received several indicative term sheets from banks and discussions are ongoing. The Company will continue to update the market on progress as appropriate.

RIP JT Macs .
Well respected shipmate.
Will raise a glass to you when the deal is done that's for sure .

Must admit i didn't have a long term strategy when I bought in at 55p awhile ago .
However , after missing the spike , and going into the red , it joined the ranks of most of my other shares in becoming a long term hold lol .

As a new CEO , and one that has been visible as a Boris in a fridge so far , would be nice to start off with an announcement that the DHSC dispute is sorted ( one way or another ) and we can move on .
Either way , you'd like your first announcement to at least be some good news !

This action does seem limited to NCYT and ABDX today - some sort of dispute resolution is the only connection I can see .
Otherwise ODX and AVCT may have budged too .

France up about 11% - must be some news coming ?

Yrjö Wichmann's presentation was just a repeat of the latest slides .
Just laid out the roadmap for trials etc , and the science behind the therapies .
Nothing new I'm afraid .
They are expecting the dosing and frequency findings - 'soon' .

Just registered for the event via the link .
The blurb says it is the largest healthcare-dedicated conference in Europe ?

Starts at 10.40 am today

Maybe Markku has finally made it to Boston for some meetings .
Interesting that todays presentation warrants an RNS . It was only added a few days ago to the Calendar .
We have had plenty of other events and forums that didn't get an RNS .

Hmm , things moving at a pace now .
They are wheeling out big gun Yrjö Wichmann for tomorrows presentation.
Yrjö is VP of Financing . He used to be CFO until Toni replaced him in 2019 .

At the time of his new appointment in 2019 , Faron said - ' this will allow him to focus on the company’s “future financing and investor relationships”.'

Markku quoted at the time as saying - '“We also believe this will increase Faron's capacity to attract external financing and enable us to better maintain and develop investor relationships and target an expanded future shareholder base.'

So interesting , but not surprising to see that he is now getting involved .
Back when he moved into the role , SP was £1.03 , and Bex was still very early in its development .

Now we have two drugs getting moving in to deal making territory .

Interesting times ahead .

Bid rising into the close at the moment - 30.2p

Yes I saw that - all the main guys at the same event .
Afters years of waiting - I think our time is finally coming !

29.65 on the bid - be great to be into the 30's before news lands .

28p on the bid for mine now :-)

I got a feeling the news at the urinals this morning was so exciting , a few bankers may have urinated on their gucci loafers

Some minor updates to the clinical trial sites .
Matti Karvonen ( 5yrs serving as Farons Chief medical Officer) comes off both Hibiscus and Matins trials as the contact backup , to be replaced by two other members of the Faron team .
HIBISCUS - replaced by Gerd Totterman
MATINS - replaced by Maria Olivera

Not sure if significant , perhaps just some in house shuffling of responsibilites .
I'm guessing they have filled the post of ' Medical Director ' they advertised last month , ' the successful candidate will be overseeing strategic clinical trial progression across a variety of therapy areas .'

We must be getting close to having some more data presented .

There will be an interview available on this coming Monday - with Inderes TV - maybe get a hint of whats coming next ?